Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu
(Q40105474)
scientific article
scientific article
Language:
Current Data About
Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||||||||||
| (P304) |
6825-6843
|
||||||||||||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||||||||||||
| (P433) |
14
|
||||||||||||||||||||||||||||||||
| (P478) |
67
|
||||||||||||||||||||||||||||||||
| (P577) |
Sunday, July 1, 2007
|
||||||||||||||||||||||||||||||||
| (P1433) |
(Q326097)
|
||||||||||||||||||||||||||||||||
| (P1476) |
"Breast cancer expressing the activated HER2/neu is sensitive to gefitinib in vitro and in vivo and acquires resistance through a novel point mutation in the HER2/neu" (language: en)
|
||||||||||||||||||||||||||||||||
| (P2093) |
Marie P Piechocki
George H Yoo
Susan K Dibbley
Fulvio Lonardo
|
||||||||||||||||||||||||||||||||
| (P2860) |
(Q24647928)
|